The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Gel for Orthopedic Joint Injection Market Research Report 2024
Synopsis
Gel for Orthopedic Joint Injection is a medical procedure during which lubricating fluid is injected into a joint. Also called hyaluronic acid injections or hyaluronan injections, viscosupplementation is most commonly used to treat symptoms of symptoms of knee osteoarthritis.
Global Gel for Orthopedic Joint Injection market is projected to reach US$ 2329.4 million in 2029, increasing from US$ 1822 million in 2022, with the CAGR of 3.6% during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Gel for Orthopedic Joint Injection market research.
Viscosupplementation involves the injection of hyaluronic acid-based solutions into the joints to relieve pain and improve mobility in patients with osteoarthritis. Factors driving market growth include the increasing prevalence of osteoarthritis, growing aging population, and the effectiveness of viscosupplementation in managing symptoms. The market is highly competitive, with several manufacturers offering viscosupplementation devices. However, challenges such as limited insurance coverage, high treatment costs, and the availability of alternative therapies may hinder market expansion. Nonetheless, the viscosupplementation devices market holds promising opportunities, driven by the rising demand for non-surgical treatment options for osteoarthritis and ongoing research and development efforts to enhance the efficacy of viscosupplementation products.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Gel for Orthopedic Joint Injection market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Sanofi
Anika Therapeutics
Seikagaku
Zimmer Biomet
Bioventus
Ferring
LG Chem
Freda
Haohai Biological
Shanghai Jingfeng
Segment by Type
Single Injection
Three Injection
Five Injection
Segment by Application
Hospitals
Clinics
Others
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
The Gel for Orthopedic Joint Injection report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Manufacturers’ Competition Patterns
Chapter 3: Country Level Sales Analysis
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6: Manufacturers’ Outline
Chapter 7: Industry Chain, Market Channel and Customer Analysis
Chapter 8: Market Opportunities and Challenges
Chapter 9: Market Conclusions
Chapter 10: Research Methodology and Data Source
Gel for Orthopedic Joint Injection is a medical procedure during which lubricating fluid is injected into a joint. Also called hyaluronic acid injections or hyaluronan injections, viscosupplementation is most commonly used to treat symptoms of symptoms of knee osteoarthritis.
Global Gel for Orthopedic Joint Injection market is projected to reach US$ 2329.4 million in 2029, increasing from US$ 1822 million in 2022, with the CAGR of 3.6% during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Gel for Orthopedic Joint Injection market research.
Viscosupplementation involves the injection of hyaluronic acid-based solutions into the joints to relieve pain and improve mobility in patients with osteoarthritis. Factors driving market growth include the increasing prevalence of osteoarthritis, growing aging population, and the effectiveness of viscosupplementation in managing symptoms. The market is highly competitive, with several manufacturers offering viscosupplementation devices. However, challenges such as limited insurance coverage, high treatment costs, and the availability of alternative therapies may hinder market expansion. Nonetheless, the viscosupplementation devices market holds promising opportunities, driven by the rising demand for non-surgical treatment options for osteoarthritis and ongoing research and development efforts to enhance the efficacy of viscosupplementation products.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Gel for Orthopedic Joint Injection market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Sanofi
Anika Therapeutics
Seikagaku
Zimmer Biomet
Bioventus
Ferring
LG Chem
Freda
Haohai Biological
Shanghai Jingfeng
Segment by Type
Single Injection
Three Injection
Five Injection
Segment by Application
Hospitals
Clinics
Others
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
The Gel for Orthopedic Joint Injection report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Manufacturers’ Competition Patterns
Chapter 3: Country Level Sales Analysis
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6: Manufacturers’ Outline
Chapter 7: Industry Chain, Market Channel and Customer Analysis
Chapter 8: Market Opportunities and Challenges
Chapter 9: Market Conclusions
Chapter 10: Research Methodology and Data Source
Index1 Gel for Orthopedic Joint Injection Market Overview
1.1 Product Overview and Scope of Gel for Orthopedic Joint Injection
1.2 Gel for Orthopedic Joint Injection Segment by Type
1.2.1 Global Gel for Orthopedic Joint Injection Market Value Comparison by Type (2023-2029)
1.2.2 Single Injection
1.2.3 Three Injection
1.2.4 Five Injection
1.3 Gel for Orthopedic Joint Injection Segment by Application
1.3.1 Global Gel for Orthopedic Joint Injection Market Value by Application: (2023-2029)
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Others
1.4 Global Gel for Orthopedic Joint Injection Market Size Estimates and Forecasts
1.4.1 Global Gel for Orthopedic Joint Injection Revenue 2018-2029
1.4.2 Global Gel for Orthopedic Joint Injection Sales 2018-2029
1.4.3 Global Gel for Orthopedic Joint Injection Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Gel for Orthopedic Joint Injection Market Competition by Manufacturers
2.1 Global Gel for Orthopedic Joint Injection Sales Market Share by Manufacturers (2018-2023)
2.2 Global Gel for Orthopedic Joint Injection Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Gel for Orthopedic Joint Injection Average Price by Manufacturers (2018-2023)
2.4 Global Gel for Orthopedic Joint Injection Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Gel for Orthopedic Joint Injection, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Gel for Orthopedic Joint Injection, Product Type & Application
2.7 Gel for Orthopedic Joint Injection Market Competitive Situation and Trends
2.7.1 Gel for Orthopedic Joint Injection Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Gel for Orthopedic Joint Injection Players Market Share by Revenue
2.7.3 Global Gel for Orthopedic Joint Injection Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Gel for Orthopedic Joint Injection Retrospective Market Scenario by Region
3.1 Global Gel for Orthopedic Joint Injection Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Gel for Orthopedic Joint Injection Global Gel for Orthopedic Joint Injection Sales by Region: 2018-2029
3.2.1 Global Gel for Orthopedic Joint Injection Sales by Region: 2018-2023
3.2.2 Global Gel for Orthopedic Joint Injection Sales by Region: 2024-2029
3.3 Global Gel for Orthopedic Joint Injection Global Gel for Orthopedic Joint Injection Revenue by Region: 2018-2029
3.3.1 Global Gel for Orthopedic Joint Injection Revenue by Region: 2018-2023
3.3.2 Global Gel for Orthopedic Joint Injection Revenue by Region: 2024-2029
3.4 North America Gel for Orthopedic Joint Injection Market Facts & Figures by Country
3.4.1 North America Gel for Orthopedic Joint Injection Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Gel for Orthopedic Joint Injection Sales by Country (2018-2029)
3.4.3 North America Gel for Orthopedic Joint Injection Revenue by Country (2018-2029)
3.4.4 United States
3.4.5 Canada
3.5 Europe Gel for Orthopedic Joint Injection Market Facts & Figures by Country
3.5.1 Europe Gel for Orthopedic Joint Injection Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Gel for Orthopedic Joint Injection Sales by Country (2018-2029)
3.5.3 Europe Gel for Orthopedic Joint Injection Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Gel for Orthopedic Joint Injection Market Facts & Figures by Country
3.6.1 Asia Pacific Gel for Orthopedic Joint Injection Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Gel for Orthopedic Joint Injection Sales by Country (2018-2029)
3.6.3 Asia Pacific Gel for Orthopedic Joint Injection Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Gel for Orthopedic Joint Injection Market Facts & Figures by Country
3.7.1 Latin America Gel for Orthopedic Joint Injection Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Gel for Orthopedic Joint Injection Sales by Country (2018-2029)
3.7.3 Latin America Gel for Orthopedic Joint Injection Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Gel for Orthopedic Joint Injection Market Facts & Figures by Country
3.8.1 Middle East and Africa Gel for Orthopedic Joint Injection Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Gel for Orthopedic Joint Injection Sales by Country (2018-2029)
3.8.3 Middle East and Africa Gel for Orthopedic Joint Injection Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Gel for Orthopedic Joint Injection Sales by Type (2018-2029)
4.1.1 Global Gel for Orthopedic Joint Injection Sales by Type (2018-2023)
4.1.2 Global Gel for Orthopedic Joint Injection Sales by Type (2024-2029)
4.1.3 Global Gel for Orthopedic Joint Injection Sales Market Share by Type (2018-2029)
4.2 Global Gel for Orthopedic Joint Injection Revenue by Type (2018-2029)
4.2.1 Global Gel for Orthopedic Joint Injection Revenue by Type (2018-2023)
4.2.2 Global Gel for Orthopedic Joint Injection Revenue by Type (2024-2029)
4.2.3 Global Gel for Orthopedic Joint Injection Revenue Market Share by Type (2018-2029)
4.3 Global Gel for Orthopedic Joint Injection Price by Type (2018-2029)
5 Segment by Application
5.1 Global Gel for Orthopedic Joint Injection Sales by Application (2018-2029)
5.1.1 Global Gel for Orthopedic Joint Injection Sales by Application (2018-2023)
5.1.2 Global Gel for Orthopedic Joint Injection Sales by Application (2024-2029)
5.1.3 Global Gel for Orthopedic Joint Injection Sales Market Share by Application (2018-2029)
5.2 Global Gel for Orthopedic Joint Injection Revenue by Application (2018-2029)
5.2.1 Global Gel for Orthopedic Joint Injection Revenue by Application (2018-2023)
5.2.2 Global Gel for Orthopedic Joint Injection Revenue by Application (2024-2029)
5.2.3 Global Gel for Orthopedic Joint Injection Revenue Market Share by Application (2018-2029)
5.3 Global Gel for Orthopedic Joint Injection Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Sanofi
6.1.1 Sanofi Corporation Information
6.1.2 Sanofi Description and Business Overview
6.1.3 Sanofi Gel for Orthopedic Joint Injection Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Sanofi Gel for Orthopedic Joint Injection Product Portfolio
6.1.5 Sanofi Recent Developments/Updates
6.2 Anika Therapeutics
6.2.1 Anika Therapeutics Corporation Information
6.2.2 Anika Therapeutics Description and Business Overview
6.2.3 Anika Therapeutics Gel for Orthopedic Joint Injection Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Anika Therapeutics Gel for Orthopedic Joint Injection Product Portfolio
6.2.5 Anika Therapeutics Recent Developments/Updates
6.3 Seikagaku
6.3.1 Seikagaku Corporation Information
6.3.2 Seikagaku Description and Business Overview
6.3.3 Seikagaku Gel for Orthopedic Joint Injection Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Seikagaku Gel for Orthopedic Joint Injection Product Portfolio
6.3.5 Seikagaku Recent Developments/Updates
6.4 Zimmer Biomet
6.4.1 Zimmer Biomet Corporation Information
6.4.2 Zimmer Biomet Description and Business Overview
6.4.3 Zimmer Biomet Gel for Orthopedic Joint Injection Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Zimmer Biomet Gel for Orthopedic Joint Injection Product Portfolio
6.4.5 Zimmer Biomet Recent Developments/Updates
6.5 Bioventus
6.5.1 Bioventus Corporation Information
6.5.2 Bioventus Description and Business Overview
6.5.3 Bioventus Gel for Orthopedic Joint Injection Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Bioventus Gel for Orthopedic Joint Injection Product Portfolio
6.5.5 Bioventus Recent Developments/Updates
6.6 Ferring
6.6.1 Ferring Corporation Information
6.6.2 Ferring Description and Business Overview
6.6.3 Ferring Gel for Orthopedic Joint Injection Sales, Revenue and Gross Margin (2018-2023)
6.6.4 Ferring Gel for Orthopedic Joint Injection Product Portfolio
6.6.5 Ferring Recent Developments/Updates
6.7 LG Chem
6.6.1 LG Chem Corporation Information
6.6.2 LG Chem Description and Business Overview
6.6.3 LG Chem Gel for Orthopedic Joint Injection Sales, Revenue and Gross Margin (2018-2023)
6.4.4 LG Chem Gel for Orthopedic Joint Injection Product Portfolio
6.7.5 LG Chem Recent Developments/Updates
6.8 Freda
6.8.1 Freda Corporation Information
6.8.2 Freda Description and Business Overview
6.8.3 Freda Gel for Orthopedic Joint Injection Sales, Revenue and Gross Margin (2018-2023)
6.8.4 Freda Gel for Orthopedic Joint Injection Product Portfolio
6.8.5 Freda Recent Developments/Updates
6.9 Haohai Biological
6.9.1 Haohai Biological Corporation Information
6.9.2 Haohai Biological Description and Business Overview
6.9.3 Haohai Biological Gel for Orthopedic Joint Injection Sales, Revenue and Gross Margin (2018-2023)
6.9.4 Haohai Biological Gel for Orthopedic Joint Injection Product Portfolio
6.9.5 Haohai Biological Recent Developments/Updates
6.10 Shanghai Jingfeng
6.10.1 Shanghai Jingfeng Corporation Information
6.10.2 Shanghai Jingfeng Description and Business Overview
6.10.3 Shanghai Jingfeng Gel for Orthopedic Joint Injection Sales, Revenue and Gross Margin (2018-2023)
6.10.4 Shanghai Jingfeng Gel for Orthopedic Joint Injection Product Portfolio
6.10.5 Shanghai Jingfeng Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Gel for Orthopedic Joint Injection Industry Chain Analysis
7.2 Gel for Orthopedic Joint Injection Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Gel for Orthopedic Joint Injection Production Mode & Process
7.4 Gel for Orthopedic Joint Injection Sales and Marketing
7.4.1 Gel for Orthopedic Joint Injection Sales Channels
7.4.2 Gel for Orthopedic Joint Injection Distributors
7.5 Gel for Orthopedic Joint Injection Customers
8 Gel for Orthopedic Joint Injection Market Dynamics
8.1 Gel for Orthopedic Joint Injection Industry Trends
8.2 Gel for Orthopedic Joint Injection Market Drivers
8.3 Gel for Orthopedic Joint Injection Market Challenges
8.4 Gel for Orthopedic Joint Injection Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
